Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > UCSF conference to focus on therapeutics of the future

Some of the leading scientists in bioengineering, nanotechnology and pharmaco-genomics will gather on Tuesday, January 26, 2010 to discuss how to harness the tools of these emerging fields to develop new diagnostics and treatments for complex diseases.

UCSF conference to focus on therapeutics of the future

San Francisco, CA | Posted on January 26th, 2010

The day-long conference will serve as the inaugural symposium for the UCSF Department of Bioengineering and Therapeutic Sciences and will take place in the William J. Rutter Center on UCSF Mission Bay Campus, at 1675 Owens Street. The conference will begin at 8:00 a.m. and conclude at 4:50 p.m.

"Our goal is to drive the innovation of better, more effective, intelligent therapeutics for patients everywhere," said Kathy Giacomini, PhD, who co-chairs the department with Sarah Nelson, PhD.

"The hope is that this new department and inaugural symposium will help spur new ideas, new directions and new ways of working across academia, industry and government toward that goal," Nelson added.

The symposium marks the one-year anniversary of the first joint department between a school of medicine and a school of pharmacy in the nation. The cross-school collaborations within the new UCSF department are targeted toward addressing the need for a more strategic approach to drug development, better diagnostic tests, a clearer understanding of how patients' genetics influence their response to drugs, and the development of modern therapies to tackle currently incurable diseases such as diabetes and cancer.

The day will showcase key research in the field, including the following:

• How the new understanding of biological networks can help in developing therapeutics that target entire systems to treat complex diseases;

• How the field of genomics is changing what we know about drug transporters and population differences in disease risk and drug response;

• How collaborations between engineers and clinical scientists are contributing to translating laboratory research into real therapies for patients.

A lunchtime panel - moderated by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and QB3 Director Regis Kelly, PhD - will explore partnerships between the academic research and industry, and how these partnerships can be improved to help accelerate the pace between therapeutic research and its real-world application.

The department is a union of the former Program in Bioengineering, in the UCSF School of Medicine, and the Department of Biopharmaceutical Sciences, in the UCSF School of Pharmacy, which were joined in January 2009. Many of the department's researchers also are affiliated with the California Institute for Quantitative Biosciences (QB3), an institute headquartered on the UCSF Mission Bay Campus that pulls together biomedical researchers and quantitative scientists - physicists, engineers and computer scientists - at UCSF, UC Berkeley and UC Santa Cruz.

While other universities have combined engineering and medicine, or engineering and pharmacy, into joint departments, none other has created a collaboration focused on speeding the innovations of medicine and medical devices to "intelligent" therapeutics, according to School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD.

"The future of novel therapeutics lies in this junction between pharmacology, engineering, and biology," Koda-Kimble said. "This department and symposium are both signals of how serious we are at UCSF about shaping the future of pharmacy science and of therapeutic medicines."

A complete symposium program, with the day's schedule and backgrounds for each presenter, is available at:


About UCSF School of Medicine
The UCSF School of Medicine has a fourfold mission of education, research, patient care and public service. In spring 2009, “U.S News & World Report” ranked the school fifth nationally both for its research training and its primary care training – the only medical school in the country ranked in the top five in both categories. For more information, please visit

The UCSF School of Pharmacy is the nation’s premier graduate-level school of pharmacy, the oldest pharmacy school in the western U.S., and a wellspring for discovery and innovation in the pharmaceutical sciences, education, and the pharmaceutical care of patients. For more information, please visit

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information, see

For more information, please click here

Kristen Bole


UCSF News Office
3333 California Street
Suite 103, Box 0462
San Francisco, CA
tel: 415-476-2557
fax: 415-476-3541

Copyright © UCSF School of Medicine

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

Conductive Inks: booming to $2.8 billion by 2024 April 17th, 2014


Director Wally Pfister joins UC Berkeley neuroengineers to discuss the science behind ‘Transcendence’ April 7th, 2014

First annual science week highlights STEM pipeline and partnerships: UB, SUNY Buffalo State and ECC team up with the City of Buffalo and its schools for April 7-11 events April 3rd, 2014

Global 450 consortium announces new general manager of internal operations: TSMC’s Cheng-Chung Chien Receives Unanimous Support, Brings History of Innovation and Efficiency to Global Consortium of Companies Driving Industry Transition to 450mm Wafer Technology March 26th, 2014

NanoTecNexus to Host "Chemistry of Wine" Fundraiser in Support of STEM Education - Collaborations Key to Success - March 20th, 2014


Innovative strategy to facilitate organ repair April 18th, 2014

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014


'Exotic' material is like a switch when super thin April 18th, 2014

Innovative strategy to facilitate organ repair April 18th, 2014

Oxford Instruments Asylum Research Introduces the MFP-3D InfinityTM AFM Featuring Powerful New Capabilities and Stunning High Performance April 18th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014


INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Engineers develop new materials for hydrogen storage April 15th, 2014


Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

In latest generation of tiny biosensors, size isn't everything: UCLA researchers overturn conventional wisdom on nanowire-based diagnostic devices April 11th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014


Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Peer Reviewed and Approved for Science by the the Washington Academy of Sciences April 3rd, 2014

New JEOL-Nikon MiXcroscopy Correlative Imaging Solution March 27th, 2014

Quantum Dots Take Center Stage at Inaugural Event: QD Vision Co-Founder and CTO Dr. Seth Coe-Sullivan to Chair First Quantum Dots Forum, March 26, 2014, San Diego, CA March 25th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE